Skip to content
Subscriber Only
Businessweek
Business

Whether or Not Omicron’s a Game Changer, Variants Are Covid’s Future

Drugmakers always knew that more mutations would arise. Battling them without comprehensive data will be the new normal.
relates to Whether or Not Omicron’s a Game Changer, Variants Are Covid’s Future
Photo Illustration: 731; Photos: Getty Images

Big Pharma’s traditional playbook for developing medicines required years of data collection and trials before a treatment began its lifesaving tenure. But drugmakers last year pulled off the once-unthinkable feat of developing a vaccine against Covid-19 in less than a year. Now they’re racing even faster to adapt those shots to protect against the new omicron variant in as little as six weeks. While it may take almost that long to determine if new vaccines are truly needed to deal with the coronavirus’s latest iteration, waiting simply isn’t an option.

This is the scramble that Covid has created. The virus is so destructive that drugmakers have started scientific work to adapt vaccines before it’s even clear the changes will be necessary. The pandemic has allowed pharma giants to leverage mRNA and other new technologies to dramatically speed up research and development. They’re now faced with having to speed things up yet again to contend with the onslaught of variants.